The policy prohibits using Stability AI technology to provide medical or health advice unless the output has been reviewed by a qualified professional and the use of AI assistance and its potential limitations have been disclosed to the recipient.
This analysis describes what Stability AI's agreement states, permits, or reserves. It does not constitute a legal determination about enforceability. Regulatory applicability and practical outcomes may vary by jurisdiction, enforcement context, and individual circumstances. Read our methodology
This provision creates an affirmative operational requirement for any product or service that surfaces Stability AI outputs in medical or health contexts, requiring both qualified professional review and AI disclosure before delivery to end users. Operators in digital health, telemedicine, wellness, or consumer health information sectors must assess whether their content pipelines satisfy both conditions.
Interpretive note: The policy does not define 'qualified professional' or 'essential services' with specificity, creating interpretive uncertainty for operators in adjacent sectors such as mental health, legal, or financial advice contexts.
Under this clause, consumers receiving health or medical information generated using Stability AI technology are entitled, under the policy's terms, to have that information reviewed by a qualified professional and to receive disclosure that AI was used and may have limitations. The agreement prohibits operators from delivering such content without satisfying both requirements.
Cross-platform context
See how other platforms handle Health and Medical AI Advice Disclosure Requirement and similar clauses.
Compare across platforms →"provision of advice on essential services, including in the medical or health field, without review by a qualified professional and disclosure of the use of AI assistance and its potential limitations.Excerpt from Stability AI's Acceptable Use Policy
(1) REGULATORY LANDSCAPE: This provision engages FDA guidance on AI-enabled medical devices and software as a medical device (SaMD) for operators in the United States, as well as FTC Act obligations around deceptive health claims.
Enforcement risk, jurisdiction flags, contract triggers, and due diligence action items.
Get the research letter
Companies change their terms quietly. We read every version and catch what actually changed. One email a week on the changes that matter and what they mean.
This provision creates an affirmative operational requirement for any product or service that surfaces Stability AI outputs in medical or health contexts, requiring both qualified professional review and AI disclosure before delivery to end users. Operators in digital health, telemedicine, wellness, or consumer health information sectors must assess whether their content pipelines satisfy both conditions.
Under this clause, consumers receiving health or medical information generated using Stability AI technology are entitled, under the policy's terms, to have that information reviewed by a qualified professional and to receive disclosure that AI was used and may have limitations. The agreement prohibits operators from delivering such content without satisfying both requirements.
No. ConductAtlas is an independent monitoring service. We are not affiliated with, endorsed by, or sponsored by Stability AI.